Antimalarial Therapy and Early Retinal Changes in Patients with Rheumatoid Arthritis

Overview

Journal Br Med J

Specialty General Medicine

Date 1966 Jan 29

PMID 5902055

Citations 8

Authors

G B Arden

H Kolb

Affiliations

Soon will be listed here.

Citing Articles

An audit of the use of hydroxychloroquine in rheumatology clinics.

Worth C, Yusuf I, Turner B, Gourier H, Brooks E, Mort D Rheumatol Adv Pract. 2019; 2(1):rky013.

PMID: 31431961 PMC: 6649984. DOI: 10.1093/rap/rky013.

Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Tzekov R Doc Ophthalmol. 2005; 110(1):111-20.

PMID: 16249962 DOI: 10.1007/s10633-005-7349-6.

Chloroquine retinopathy: is there a safe daily dose?.

Marks J Ann Rheum Dis. 1982; 41(1):52-8.

PMID: 7065730 PMC: 1000864. DOI: 10.1136/ard.41.1.52.

Ultrastructural alterations in rat and cat retina and pigment epithelium induced by chloroquine.

Ivanina T, Zueva M, Lebedeva M, BOGOSLOVSKY A, Bunin A Graefes Arch Clin Exp Ophthalmol. 1983; 220(1):32-8.

PMID: 6832596 DOI: 10.1007/BF02307013.

Delayed chloroquine retinopathy.

Br Med J. 1967; 1(5535):254.

PMID: 6017471 PMC: 1840614.

References

HOBBS H, Sorsby A, FREEDMAN A . Retinopathy following chloroquine therapy. Lancet. 1959; 2(7101):478-80. DOI: 10.1016/s0140-6736(59)90604-x. View

Meier-Ruge W . EXPERIMENTAL INVESTIGATION OF THE MORPHOGENESIS OF CHLOROQUINE RETINOPATHY. Arch Ophthalmol. 1965; 73:540-4. DOI: 10.1001/archopht.1965.00970030542017. View

Henkind P, Rothfield N . Ocular abnormalities in patients treated with synthetic antimalarial drugs. N Engl J Med. 1963; 269:433-9. DOI: 10.1056/NEJM196308292690901. View

Butler I . [RETINOPATHY CAUSED BY THE USE OF CHLOROQUINE AND RELATED DRUGS]. Ned Tijdschr Geneeskd. 1965; 109:677-9. View

CAMBIAGGI A . Unusual ocular lesions in a case of systemic lupus erythematosus. AMA Arch Ophthalmol. 1957; 57(3):451-3. DOI: 10.1001/archopht.1957.00930050463019. View

Henkind P, Carr R, Siegel I . EARLY CHLOROQUINE RETINOPATHY: CLINICAL AND FUNCTIONAL FINDINGS. Arch Ophthalmol. 1964; 71:157-65. DOI: 10.1001/archopht.1964.00970010173003. View

Arden G, FOJAS M . Electrophysiological abnormalities in pigmentary degenerations of the retina. Assessment of value and basis. Arch Ophthalmol. 1962; 68:369-89. DOI: 10.1001/archopht.1962.00960030373012. View

TER BALSB . CHLOROQUINE RETINOPATHY AND ITS INCIDENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS. Acta Rheumatol Scand. 1964; 10:227-40. View

Arden G, Friedmann A, Kolb H . Anticipation of chloroquine retinopathy. Lancet. 1962; 1(7240):1164-5. DOI: 10.1016/s0140-6736(62)92200-6. View

10.

HOBBS H, Eadie S, Somerville F . OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE. Br J Ophthalmol. 1961; 45(4):284-97. PMC: 510074. DOI: 10.1136/bjo.45.4.284. View

11.

Maguire A, Kolb H . THE EFFECT OF A SYNTHETIC ANTIMALARIAL (AMODIAQUINE) ON THE RETINA. Br J Dermatol. 1964; 76:471-4. DOI: 10.1111/j.1365-2133.1964.tb15487.x. View

12.

LLOYD L, HILTZ J . OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY. Can Med Assoc J. 1965; 92:508-13. PMC: 1928171. View

13.

Kolb H . Electro-oculogram findings in patients treated with antimalarial drugs. Br J Ophthalmol. 1965; 49(11):573-90. PMC: 506163. DOI: 10.1136/bjo.49.11.573. View

14.

Arden G, Barrada A . Analysis of the electro-oculograms of a series of normal subjects: role of the lens in the development of the standing potential. Br J Ophthalmol. 1962; 46(8):468-82. PMC: 510229. DOI: 10.1136/bjo.46.8.468. View

15.

Arden G, Barrada A, Kelsey J . New clinical test of retinal function based upon the standing potential of the eye. Br J Ophthalmol. 1962; 46(8):449-67. PMC: 510228. DOI: 10.1136/bjo.46.8.449. View